NPAT up 16.4% but operating cash swung to a $43.9m outflow as borrowings...

What changed

Revenue from continuing operations rose 15.4% to $342.0m and profit before tax rose 15.4% to $43.1m, with NPAT up 16.4% to $31.3m. Growth was led by automotive retail, which increased to 70.9% of group revenue (from 67.8%), while insurance and credit management lost share. The dominant operating change, however, was in cash: net operating cash flow swung from a $10.9m inflow to a $43.9m outflow, and capex nearly doubled to $16.1m, driving pre-lease free cash flow to negative $60.1m. Gross borrowings rose 21.5% to $412.8m, lifting estimated net debt to roughly $399.4m from $327.7m. A 7.0c final dividend was declared.

What matters

• Cash conversion inverted. With P&L earnings up but operating cash flow down ~$54.8m year on year, reported profit was not backed by cash in FY22. The dividend is not covered by pre-lease free cash flow; funding instead came from additional borrowings.
• Leverage is doing the work. Borrowings grew $73.2m while equity grew only $19.4m, so the balance sheet absorbed the cash shortfall and the growth in receivables-book/inventory-linked funding. For a group where finance is the highest-margin segment (~34.7% operating margin), rising funding costs become a direct earnings sensitivity.
• Mix is tilting toward the lower-margin segment. Automotive retail margin is ~8.0% versus ~34.7% in finance and ~28.7% in insurance. Headline revenue growth is concentrated in the lower-margin engine, while the higher-margin segments either grew slower or shrank.

Expectations

No forward work or stated target was disclosed in the extracted materials, so there is no quantitative benchmark to judge against. On shape, HY22 contributed 48.1% of full-year revenue and 53.9% of full-year NPAT, so H2 was revenue-heavier but earnings-lighter — implied H2 NPAT was $14.4m versus $16.9m in H1. Annualising HY22 gives ~$329.2m of revenue versus the $342.0m delivered, consistent with a modest H2 uplift rather than acceleration. The release does not support a read on momentum into FY23; it does support the view that the second half was the weaker profit half.

Quality of result

The P&L read is clean on tax: the effective tax rate eased only slightly from 28.1% to 27.5%, so PBT growth of 15.4% is consistent with NPAT growth of 16.4%. No non-recurring items or non-GAAP adjustments were flagged. The quality concern is entirely below the earnings line. Receivable days (8.1) and inventory days (34.1) both improved modestly, so the $54.8m operating cash deterioration is not explained by simple working-capital build on trade debtors and inventory alone — it more likely reflects growth in the finance receivables book funded by borrowings, though the release excerpts do not provide a full operating-working-capital bridge. Either way, FY22 earnings are not self-funding, and the 7.0c final dividend (≈19.2% payout of NPAT) is effectively debt-funded this year.

Unresolved

• What is driving the $54.8m operating cash swing line by line — finance receivables growth, inventory funding, or something else — and is it expected to reverse?
• What are the covenant headroom, weighted cost and maturity profile on the $412.8m borrowings, and how sensitive is the finance segment margin to rising rates?
• Is the 7.0c payment the full-year dividend or only the final component, and what was the FY21 total for comparison (prior DPS was not disclosed in extraction)?
• Why did insurance and credit management revenue decline in absolute terms, and is the mix shift toward lower-margin automotive retail structural?

This briefing cannot assess segment-level cash generation, funding cost trajectory, or management commentary on outlook, because none of those were available in the extracted materials.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.